Cargando…

Assessing Agreement between miRNA Microarray Platforms

Over the last few years, miRNA microarray platforms have provided great insights into the biological mechanisms underlying the onset and development of several diseases. However, only a few studies have evaluated the concordance between different microarray platforms using methods that took into acc...

Descripción completa

Detalles Bibliográficos
Autores principales: Bassani, Niccolò P., Ambrogi, Federico, Biganzoli, Elia M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979053/
https://www.ncbi.nlm.nih.gov/pubmed/27600350
http://dx.doi.org/10.3390/microarrays3040302
_version_ 1782447264228179968
author Bassani, Niccolò P.
Ambrogi, Federico
Biganzoli, Elia M.
author_facet Bassani, Niccolò P.
Ambrogi, Federico
Biganzoli, Elia M.
author_sort Bassani, Niccolò P.
collection PubMed
description Over the last few years, miRNA microarray platforms have provided great insights into the biological mechanisms underlying the onset and development of several diseases. However, only a few studies have evaluated the concordance between different microarray platforms using methods that took into account measurement error in the data. In this work, we propose the use of a modified version of the Bland–Altman plot to assess agreement between microarray platforms. To this aim, two samples, one renal tumor cell line and a pool of 20 different human normal tissues, were profiled using three different miRNA platforms (Affymetrix, Agilent, Illumina) on triplicate arrays. Intra-platform reliability was assessed by calculating pair-wise concordance correlation coefficients (CCC) between technical replicates and overall concordance correlation coefficient (OCCC) with bootstrap percentile confidence intervals, which revealed moderate-to-good repeatability of all platforms for both samples. Modified Bland–Altman analysis revealed good patterns of concordance for Agilent and Illumina, whereas Affymetrix showed poor-to-moderate agreement for both samples considered. The proposed method is useful to assess agreement between array platforms by modifying the original Bland–Altman plot to let it account for measurement error and bias correction and can be used to assess patterns of concordance between other kinds of arrays other than miRNA microarrays.
format Online
Article
Text
id pubmed-4979053
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-49790532016-09-06 Assessing Agreement between miRNA Microarray Platforms Bassani, Niccolò P. Ambrogi, Federico Biganzoli, Elia M. Microarrays (Basel) Article Over the last few years, miRNA microarray platforms have provided great insights into the biological mechanisms underlying the onset and development of several diseases. However, only a few studies have evaluated the concordance between different microarray platforms using methods that took into account measurement error in the data. In this work, we propose the use of a modified version of the Bland–Altman plot to assess agreement between microarray platforms. To this aim, two samples, one renal tumor cell line and a pool of 20 different human normal tissues, were profiled using three different miRNA platforms (Affymetrix, Agilent, Illumina) on triplicate arrays. Intra-platform reliability was assessed by calculating pair-wise concordance correlation coefficients (CCC) between technical replicates and overall concordance correlation coefficient (OCCC) with bootstrap percentile confidence intervals, which revealed moderate-to-good repeatability of all platforms for both samples. Modified Bland–Altman analysis revealed good patterns of concordance for Agilent and Illumina, whereas Affymetrix showed poor-to-moderate agreement for both samples considered. The proposed method is useful to assess agreement between array platforms by modifying the original Bland–Altman plot to let it account for measurement error and bias correction and can be used to assess patterns of concordance between other kinds of arrays other than miRNA microarrays. MDPI 2014-12-12 /pmc/articles/PMC4979053/ /pubmed/27600350 http://dx.doi.org/10.3390/microarrays3040302 Text en © 2014 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Bassani, Niccolò P.
Ambrogi, Federico
Biganzoli, Elia M.
Assessing Agreement between miRNA Microarray Platforms
title Assessing Agreement between miRNA Microarray Platforms
title_full Assessing Agreement between miRNA Microarray Platforms
title_fullStr Assessing Agreement between miRNA Microarray Platforms
title_full_unstemmed Assessing Agreement between miRNA Microarray Platforms
title_short Assessing Agreement between miRNA Microarray Platforms
title_sort assessing agreement between mirna microarray platforms
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979053/
https://www.ncbi.nlm.nih.gov/pubmed/27600350
http://dx.doi.org/10.3390/microarrays3040302
work_keys_str_mv AT bassaniniccolop assessingagreementbetweenmirnamicroarrayplatforms
AT ambrogifederico assessingagreementbetweenmirnamicroarrayplatforms
AT biganzolieliam assessingagreementbetweenmirnamicroarrayplatforms